Inventor
STERLING JEFFREY
IL27 patents
⚠️ This page may combine multiple inventors who share the name “STERLING JEFFREY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TEVA PHARMA
16 patentsUS5457133AOct 10, 1995
R-enantiomers of N-propargyl-aminoindan compounds, their preparation and pharmaceutical compositions containing them
TEVA PHARMA112 citations99
US6630514B2Oct 7, 2003
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
TEVA PHARMA77 citations98
US5786390AJul 28, 1998
Pharmaceutical compositions of the R-enantiomer of N-propargyl -1-aminoindan
TEVA PHARMA105 citations98
US5532415AJul 2, 1996
R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof
TEVA PHARMA169 citations98
US5744500AApr 28, 1998
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
TEVA PHARMA100 citations97
US5599991AFeb 4, 1997
Esylate and sulfate salts of R(+)-N-propargyl-1-aminoindan
TEVA PHARMA84 citations97
US5453446ASep 26, 1995
Use of the R-enantiomers of N-propargyl 1-aminoindan compounds for treating Parkinson's disease.
TEVA PHARMA104 citations97
US5387612AFeb 7, 1995
Use of the R-enantiomers of N-propargyl-1-aminoindan compounds for treating Parkinson's disease
TEVA PHARMA114 citations97
US7598420B1Oct 6, 2009
Rasagiline formulations and processes for their preparation
TEVA PHARMA46 citations93
US7572834B1Aug 11, 2009
Rasagiline formulations and processes for their preparation
TEVA PHARMA49 citations93
US6538025B2Mar 25, 2003
Aminoindan derivatives
TEVA PHARMA31 citations92
US6251938B1Jun 26, 2001
Phenylethylamine derivatives
TEVA PHARMA45 citations92
US5646188AJul 8, 1997
Polyamine derivatives of 1-aminoindan
TEVA PHARMA46 citations91
US4202892AMay 13, 1980
Biocidal methyladamantyl hydrazines and pharmaceutical compositions containing them
TEVA PHARMA10 citations70
US4758382AJul 19, 1988
Process for the stereospecific preparation of 24(R),25- and 24(S),25-dihydroxycholecalciferol and novel intermediates used therefor
TEVA PHARMA10 citations65
US4254128AMar 3, 1981
2-Adamantyl hydrazines and biocidal compositions thereof
TEVA PHARMA5 citations59
TECHNION RES & DEV FOUNDATION
3 patentsUS6316504B1Nov 13, 2001
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
TECHNION RES & DEV FOUNDATION98 citations99
US6956060B2Oct 18, 2005
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
TECHNION RES & DEV FOUNDATION57 citations96
USRE39616EMay 8, 2007
Aminoindan derivatives
TECHNION RES & DEV FOUNDATION9 citations73